These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35328646)

  • 1. Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence.
    Koliaki C; Katsilambros N
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin promotes vascular smooth muscle cell proliferation and apoptosis via differential regulation of tumor necrosis factor-related apoptosis-inducing ligand.
    Harith HH; Di Bartolo BA; Cartland SP; Genner S; Kavurma MM
    J Diabetes; 2016 Jul; 8(4):568-78. PubMed ID: 26333348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes.
    Lamhamedi-Cherradi SE; Zheng S; Tisch RM; Chen YH
    Diabetes; 2003 Sep; 52(9):2274-8. PubMed ID: 12941766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.
    Mi QS; Ly D; Lamhamedi-Cherradi SE; Salojin KV; Zhou L; Grattan M; Meagher C; Zucker P; Chen YH; Nagle J; Taub D; Delovitch TL
    Diabetes; 2003 Aug; 52(8):1967-75. PubMed ID: 12882912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
    J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.
    Cheung SS; Metzger DL; Wang X; Huang J; Tai J; Tingle AJ; Ou D
    Pancreas; 2005 Mar; 30(2):105-14. PubMed ID: 15714132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes.
    Vaccarezza M; Delbello G; Zauli G
    Acta Biomed; 2007; 78 Suppl 1():262-7. PubMed ID: 17465340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E; Vodjgani M; Massoud A; Keyhani A; Rajab A; Shafaghi B; Gheflati Z; Aboufazeli T
    Iran J Immunol; 2007 Dec; 4(4):197-205. PubMed ID: 18057577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
    Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
    Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
    J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
    Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.
    Perri P; Zauli G; Gonelli A; Milani D; Celeghini C; Lamberti G; Secchiero P
    Biomed Res Int; 2015; 2015():424019. PubMed ID: 25834817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes.
    Zauli G; Toffoli B; di Iasio MG; Celeghini C; Fabris B; Secchiero P
    Diabetes; 2010 May; 59(5):1261-5. PubMed ID: 20185810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL induces proliferation in rodent pancreatic beta cells via AKT activation.
    Kahraman S; Yilmaz O; Altunbas HA; Dirice E; Sanlioglu AD
    J Mol Endocrinol; 2021 May; 66(4):325-338. PubMed ID: 33875613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
    Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
    Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.